Caliber Imaging & Diagnostics Appoints Daniel Mark Siegel, M.D. to Its Board of Directors
13 Janeiro 2014 - 10:00AM
Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid,
Inc., announces the appointment of Daniel Mark Siegel, M.D. to its
Board of Directors, effective immediately. This increases the
number of Board members to eight.
Dr. Siegel, age 56, is Clinical Professor of Dermatology at SUNY
Downstate Medical Center (State University of New York Health
Sciences Center at Brooklyn) and is in private practice at Long
Island Skin Cancer and Dermatologic Surgery in Smithtown, N.Y., a
division of ProHealthcare. He also is an attending physician at
SUNY Downstate Medical Center-University Hospital of Brooklyn and
at the Brooklyn Campus of the Veterans Administration New York
Harbor Healthcare System, and is on the medical staff at Eastern
Long Island Hospital in Greenport, N.Y.
Dr. Siegel said, "As a practicing dermatologist and a professor
of dermatology, I am acutely aware of the need for new diagnostic
tools for skin cancers, specifically noninvasive options. The
VivaScope® system developed by Caliber I.D. represents an exciting
and innovative advancement in this area. I am looking forward to
working with the Caliber executive team as they seek to further
develop this technology and raise awareness of it among the medical
community worldwide."
L. Michael Hone, Chief Executive Officer of Caliber I.D., said,
"Dr. Siegel brings tremendous experience to the Company, and we are
privileged to have him serve on our Board. We believe his extensive
background in the challenges of skin cancer diagnosis, and his deep
understanding of patient needs and concerns will serve us
well."
Dr. Siegel is a Fellow and Immediate Past President of the
American Academy of Dermatology and the American Society for
Dermatologic Surgery. He holds an M.S. in management and policy
from the State University of New York at Stony Brook, an M.D. from
Albany Medical College and a B.A. from Rensselaer Polytechnic
Institute. Dr. Siegel has also published numerous papers in
peer-reviewed journals.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' proprietary, cutting-edge
VivaScope® system is a disruptive, noninvasive point-of-care
platform imaging technology with numerous applications in
dermatology, surgery and research. FDA 510(k) cleared, VivaScope
has regulatory approval in most major markets. With 78 issued and
pending patents worldwide, VivaScope significantly improves
outcomes and reduces costs, allowing physicians to quickly detect
cancerous lesions that appear benign. VivaScope dramatically
reduces the need for expensive, painful and time-consuming
biopsies, which show no malignancy approximately 70% of the time.
VivaScope also has significant applications in testing and analysis
in the cosmetics industry. For more information about Caliber I.D.
and its products, please visit www.caliberid.com.
VivaScope® is a registered trademark of Caliber Imaging &
Diagnostics.
Safe Harbor
This press release contains "forward looking statements" within
the meaning of the Securities Litigation Reform Act of 1995. These
statements are based on our current beliefs or expectations and are
inherently subject to significant known and unknown uncertainties
and changes in circumstances, many of which are beyond our control.
There can be no assurance that our beliefs or expectations will be
achieved and actual results may differ materially from our beliefs
or expectations due to financial, economic, business, regulatory
and other factors or conditions affecting us or our industry in
general, as well as more specific risks and uncertainties facing
us, such as those set forth in the Risk Factors section of the
Forms 10-Q and 10-K filed by us with the Securities and Exchange
Commission.
CONTACT: Company Contact:
Richard Pulsifer
Chief Financial Officer
(617) 348-9821
Investor Relations Contact:
LHA
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
Public Relations Contacts:
Dian Griesel Int'l.
Susan Forman or Laura Radocaj
(212) 825-3210
sforman@dgicomm.com
lradocaj@dgicomm.com
Caliber Imaging and Diag... (CE) (USOTC:LCDX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Caliber Imaging and Diag... (CE) (USOTC:LCDX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024